News
Vantia Therapeutics appoints new CEO
9 June 2010
Vantia Therapeutics today announced that it has appointed Andrew Crockett to the position of Chief Executive Officer (CEO). more»
VA111913 structure revealed
26 March 2010
Vantia Therapeutics reveals structure of its novel small molecule treatment for dysmenorrhoea, VA111913, at the ACS National Meeting. more»
Current Vacancies
Vantia Therapeutics currently has no vacancies.
